Contact hours available until 2/28/17.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Authors Conflict of Interest Disclosure:
The authors reported no actual or potential conflict of interest in relation to this continuing nursing education activity.

Nephrology Nursing Journal Editorial Board Statements of Disclosure

In accordance with ANCC governing rules Nephrology Nursing Journal Editorial Board statements of disclosure are published with each CNE offering. The statements of disclosure for this offering are published below.

Paula Dutka MSN, RN, CNN, disclosed that she is a coordinator of Clinical Trials for the following sponsors: Amgen, Rockwell Medical, Keryx Biopharmaceuticals, Akebia Therapeutics, and Dynavax Technologies.

Carol M. Headley DNSc, ACNP-BC, RN, CNN, disclosed that she is a Consultant and/or member of the Corporate Speaker’s Bureau for Sanofi Renal, and a member of the Advisory Board for Amgen.

Tamara M. Kear, PhD, RN, CNS, CNN, disclosed that she is a Fresenius employee, freelance editor for Lippincott Williams & Wilkins and Elsevier publishing companies, and a consultant for Symplmed.

All other members of the Editorial Board had no actual or potential conflict of interest in relation to this continuing nursing education activity.

This article was reviewed and formatted for contact hour credit by Beth Ulrich, EdD, RN, FACHE, FAAN, Nephrology Nursing Journal Editor, and Hazel A. Dennison, DNP, RN, APNc, CPHQ, CNE, ANNA Education Director.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Goal
Understand the cardiovascular risk factors for patients with ESRD who are on dialysis and ways to potentially mitigate these risks.

Objectives:

Identify the impact from the traditional CVD risk factors in patients on dialysis.
Discuss non-traditional CVD risk factors that relate to patients with ESRD and their dialysis treatment.
Discuss implications to nephrology community based on the latest evidence-based practice.

Delia Deng BSN, RN

Appearances